191 related articles for article (PubMed ID: 9234750)
41. Protection of Aotus monkeys after immunization with recombinant antigens of Plasmodium falciparum.
Enders B; Hundt E; Knapp B
Mem Inst Oswaldo Cruz; 1992; 87 Suppl 3():413-22. PubMed ID: 1343721
[TBL] [Abstract][Full Text] [Related]
42. Protective efficacy against malaria of a combination sporozoite and erythrocytic stage vaccine.
Wang R; Charoenvit Y; Daly TM; Long CA; Corradin G; Hoffman SL
Immunol Lett; 1996 Nov; 53(2-3):83-93. PubMed ID: 9024983
[TBL] [Abstract][Full Text] [Related]
43. Members of the merozoite surface protein 7 family with similar expression patterns differ in ability to protect against Plasmodium yoelii malaria.
Mello K; Daly TM; Long CA; Burns JM; Bergman LW
Infect Immun; 2004 Feb; 72(2):1010-8. PubMed ID: 14742548
[TBL] [Abstract][Full Text] [Related]
44. Production, characterisation and immunogenicity of a plant-made Plasmodium antigen--the 19 kDa C-terminal fragment of Plasmodium yoelii merozoite surface protein 1.
Ma C; Wang L; Webster DE; Campbell AE; Coppel RL
Appl Microbiol Biotechnol; 2012 Apr; 94(1):151-61. PubMed ID: 22170105
[TBL] [Abstract][Full Text] [Related]
45. Rhop-3 protein conservation among Plasmodium species and induced protection against lethal P. yoelii and P. berghei challenge.
Wang T; Fujioka H; Drazba JA; Sam-Yellowe TY
Parasitol Res; 2006 Aug; 99(3):238-52. PubMed ID: 16541261
[TBL] [Abstract][Full Text] [Related]
46. Protective immunization with a novel membrane protein of Plasmodium yoelii-infected erythrocytes.
Burns JM; Adeeku EK; Dunn PD
Infect Immun; 1999 Feb; 67(2):675-80. PubMed ID: 9916076
[TBL] [Abstract][Full Text] [Related]
47. Inhibition of 19-kDa C-terminal region of merozoite surface protein-1-specific antibody responses in neonatal pups by maternally derived 19-kDa C-terminal region of merozoite surface protein-1-specific antibodies but not whole parasite-specific antibodies.
Stanisic DI; Martin LB; Gatton ML; Good MF
J Immunol; 2004 May; 172(9):5570-81. PubMed ID: 15100300
[TBL] [Abstract][Full Text] [Related]
48. Merozoite surface protein-1 of Plasmodium yoelii fused via an oligosaccharide moiety of cholera toxin B subunit glycoprotein expressed in yeast induced protective immunity against lethal malaria infection in mice.
Miyata T; Harakuni T; Taira T; Matsuzaki G; Arakawa T
Vaccine; 2012 Jan; 30(5):948-58. PubMed ID: 22119928
[TBL] [Abstract][Full Text] [Related]
49. The clinical-grade 42-kilodalton fragment of merozoite surface protein 1 of Plasmodium falciparum strain FVO expressed in Escherichia coli protects Aotus nancymai against challenge with homologous erythrocytic-stage parasites.
Darko CA; Angov E; Collins WE; Bergmann-Leitner ES; Girouard AS; Hitt SL; McBride JS; Diggs CL; Holder AA; Long CA; Barnwell JW; Lyon JA
Infect Immun; 2005 Jan; 73(1):287-97. PubMed ID: 15618165
[TBL] [Abstract][Full Text] [Related]
50. Intranasal immunization with yeast-expressed 19 kD carboxyl-terminal fragment of Plasmodium yoelii merozoite surface protein-1 (yMSP119) induces protective immunity to blood stage malaria infection in mice.
Hirunpetcharat C; Stanisic D; Liu XQ; Vadolas J; Strugnell RA; Lee R; Miller LH; Kaslow DC; Good MF
Parasite Immunol; 1998 Sep; 20(9):413-20. PubMed ID: 9767608
[TBL] [Abstract][Full Text] [Related]
51. Genetic linkage of autologous T cell epitopes in a chimeric recombinant construct improves anti-parasite and anti-disease protective effect of a malaria vaccine candidate.
Singh B; Cabrera-Mora M; Jiang J; Galinski M; Moreno A
Vaccine; 2010 Mar; 28(14):2580-92. PubMed ID: 20097151
[TBL] [Abstract][Full Text] [Related]
52. Plasmodium yoelii: the role of the individual epidermal growth factor-like domains of the merozoite surface protein-1 in protection from malaria.
Calvo PA; Daly TM; Long CA
Exp Parasitol; 1996 Jan; 82(1):54-64. PubMed ID: 8617331
[TBL] [Abstract][Full Text] [Related]
53. Improved immunogenicity and efficacy of the recombinant 19-kilodalton merozoite surface protein 1 by the addition of oligodeoxynucleotide and aluminum hydroxide gel in a murine malaria vaccine model.
Near KA; Stowers AW; Jankovic D; Kaslow DC
Infect Immun; 2002 Feb; 70(2):692-701. PubMed ID: 11796601
[TBL] [Abstract][Full Text] [Related]
54. The combined epidermal growth factor-like modules of Plasmodium yoelii Merozoite Surface Protein-1 are required for a protective immune response to the parasite.
Ling IT; Ogun SA; Holder AA
Parasite Immunol; 1995 Aug; 17(8):425-33. PubMed ID: 7501423
[TBL] [Abstract][Full Text] [Related]
55. The structure of Plasmodium yoelii merozoite surface protein 119, antibody specificity and implications for malaria vaccine design.
Curd RD; Birdsall B; Kadekoppala M; Ogun SA; Kelly G; Holder AA
Open Biol; 2014 Jan; 4(1):130091. PubMed ID: 24403012
[TBL] [Abstract][Full Text] [Related]
56. Genetic regulation of protective immune response in congenic strains of mice vaccinated with a subunit malaria vaccine.
Tian JH; Miller LH; Kaslow DC; Ahlers J; Good MF; Alling DW; Berzofsky JA; Kumar S
J Immunol; 1996 Aug; 157(3):1176-83. PubMed ID: 8757623
[TBL] [Abstract][Full Text] [Related]
57. Effect of Plasmodium yoelii exposure on vaccination with the 19-kilodalton carboxyl terminus of merozoite surface protein 1 and vice versa and implications for the application of a human malaria vaccine.
Wipasa J; Xu H; Liu X; Hirunpetcharat C; Stowers A; Good MF
Infect Immun; 2009 Feb; 77(2):817-24. PubMed ID: 19015251
[TBL] [Abstract][Full Text] [Related]
58. A recombinant baculovirus 42-kilodalton C-terminal fragment of Plasmodium falciparum merozoite surface protein 1 protects Aotus monkeys against malaria.
Chang SP; Case SE; Gosnell WL; Hashimoto A; Kramer KJ; Tam LQ; Hashiro CQ; Nikaido CM; Gibson HL; Lee-Ng CT; Barr PJ; Yokota BT; Hut GS
Infect Immun; 1996 Jan; 64(1):253-61. PubMed ID: 8557348
[TBL] [Abstract][Full Text] [Related]
59. Monoclonal antibodies of three different immunoglobulin G isotypes produced by immunization with a synthetic peptide or native protein protect mice against challenge with Plasmodium yoelii sporozoites.
Ak M; Bower JH; Hoffman SL; Sedegah M; Lees A; Carter M; Beaudoin RL; Charoenvit Y
Infect Immun; 1993 Jun; 61(6):2493-7. PubMed ID: 8500885
[TBL] [Abstract][Full Text] [Related]
60. Induction of protective polyclonal antibodies by immunization with a Plasmodium yoelii circumsporozoite protein multiple antigen peptide vaccine.
Wang R; Charoenvit Y; Corradin G; Porrozzi R; Hunter RL; Glenn G; Alving CR; Church P; Hoffman SL
J Immunol; 1995 Mar; 154(6):2784-93. PubMed ID: 7876549
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
